Skip to main content

Advertisement

SpringerLink
Log in

Bone and mineral metabolism in patients undergoing Roux-en-Y gastric bypass

  • Review
  • Published:
Osteoporosis International Aims and scope Submit manuscript

Abstract

Summary

Despite effective weight reduction, the impact of bariatric surgery on bone is a major concern. Mechanisms include decreased mechanical loading, calcium and vitamin D malabsorption, deficiency in other nutrients, and alterations in fat- and gut-derived hormones. The evidence to support clinical care pathways to prevent bone loss and fractures is at this point weak.

Introduction

There is a growing concern regarding the potential deleterious impact of bariatric surgery on bone metabolism. This comprehensive review addresses this controversial topic.

Methods

We reviewed and analyzed articles evaluating bone metabolism and mechanisms for the ensuing putative bone loss in adult patients exclusively undergoing Roux-en-Y gastric bypass (RYGB) surgery, for the period spanning 1942 till September 2012.

Results

Mechanisms identified to contribute to alterations in bone metabolism after bypass surgery include: decreased mechanical loading, calcium and vitamin D malabsorption with secondary hyperparathyroidism, deficiency in other nutrients, in addition to alterations in adipokines, gonadal steroids, and gut-derived hormones favoring bone loss, with the exception of serotonin and glucagon-like peptide-1. The relative contribution of each of these hormones to changes in bone homeostasis after bypass surgery remains undefined. Bone loss reflected by a decline in bone mineral density (BMD) and an increase in bone turnover markers have been reported in many studies, limited for the most part by the exclusive use of dual energy X-ray absorptiometry. Well-designed long-term prospective trials with fractures as an outcome, and studies investigating the magnitude, reversibility, and impact of the observed metabolic changes on fracture outcomes are lacking.

Conclusion

Robust conclusions regarding bone loss and fracture outcome after RYGB surgery cannot be drawn at this time. Although not evidence based, baseline evaluation and sequential monitoring with measurement of BMD and calciotropic hormones seem appropriate, with adequate calcium and vitamin D replacement. Beneficial interventions remain unclear.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Flegal KM, Carroll MD, Kit BK, Ogden CL (2012) Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010. JAMA 307:491–497

    PubMed  Google Scholar 

  2. (2008) Obesity and Overweight. World Health Organization. http://www.who.int/mediacentre/factsheets/fs311/en

  3. Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, Schoelles K (2004) Bariatric surgery: a systematic review and meta-analysis. JAMA 292:1724–1737

    CAS  PubMed  Google Scholar 

  4. Kleinman NL, Melkonian A, St B, Rohrbacker N, Lynch WD, Gardner HH (2009) The impact of morbid obesity and bariatric surgery on comorbid conditions: a comprehensive examination of comorbidities in an employed population. J Occup Environ Med 51:170–179

    PubMed  Google Scholar 

  5. Carlos do Rego Furtado L (2010) Procedure and outcomes of Roux-en-Y gastric bypass. Br J Nurs 19:307–313

    PubMed  Google Scholar 

  6. Folli F, Sabowitz BN, Schwesinger W, Fanti P, Guardado-Mendoza R, Muscogiuri G (2012) Bariatric surgery and bone disease: from clinical perspective to molecular insights. Int J Obes (Lond) 36:1373–1379

    CAS  Google Scholar 

  7. Buchwald H, Buchwald JN (2002) Evolution of operative procedures for the management of morbid obesity 1950–2000. Obes Surg 12:705–717

    PubMed  Google Scholar 

  8. Adrian TE, Ferri GL, Bacarese-Hamilton AJ, Fuessl HS, Polak JM, Bloom SR (1985) Human distribution and release of a putative new gut hormone, peptide YY. Gastroenterology 89:1070–1077

    CAS  PubMed  Google Scholar 

  9. Batterham RL, Bloom SR (2003) The gut hormone peptide YY regulates appetite. Ann N Y Acad Sci 994:162–168

    CAS  PubMed  Google Scholar 

  10. Batterham RL, Cohen MA, Ellis SM, Le Roux CW, Withers DJ, Frost GS, Ghatei MA, Bloom SR (2003) Inhibition of food intake in obese subjects by peptide YY3-36. N Engl J Med 349:941–948

    CAS  PubMed  Google Scholar 

  11. le Roux CW, Batterham RL, Aylwin SJ et al (2006) Attenuated peptide YY release in obese subjects is associated with reduced satiety. Endocrinology 147:3–8

    PubMed  Google Scholar 

  12. Reid IR (2002) Relationships among body mass, its components, and bone. Bone 31:547–555

    CAS  PubMed  Google Scholar 

  13. Misra M, Miller KK, Tsai P, Gallagher K, Lin A, Lee N, Herzog DB, Klibanski A (2006) Elevated peptide YY levels in adolescent girls with anorexia nervosa. J Clin Endocrinol Metab 91:1027–1033

    CAS  PubMed  Google Scholar 

  14. Russell M, Stark J, Nayak S, Miller KK, Herzog DB, Klibanski A, Misra M (2009) Peptide YY in adolescent athletes with amenorrhea, eumenorrheic athletes and non-athletic controls. Bone 45:104–109

    CAS  PubMed Central  PubMed  Google Scholar 

  15. Baldock PA, Sainsbury A, Couzens M, Enriquez RF, Thomas GP, Gardiner EM, Herzog H (2002) Hypothalamic Y2 receptors regulate bone formation. J Clin Invest 109:915–921

    CAS  PubMed Central  PubMed  Google Scholar 

  16. Wong IP, Driessler F, Khor EC et al (2012) Peptide YY regulates bone remodeling in mice: a link between gut and skeletal biology. PLoS One 7:e40038

    CAS  PubMed Central  PubMed  Google Scholar 

  17. Wortley KE, Garcia K, Okamoto H et al (2007) Peptide YY regulates bone turnover in rodents. Gastroenterology 133:1534–1543

    CAS  PubMed  Google Scholar 

  18. Dirksen C, Jorgensen NB, Bojsen-Moller KN, Jacobsen SH, Hansen DL, Worm D, Holst JJ, Madsbad S (2012) Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass. Diabetologia 55:1890–1901

    CAS  PubMed  Google Scholar 

  19. Vilsboll T, Krarup T, Sonne J, Madsbad S, Volund A, Juul AG, Holst JJ (2003) Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus. J Clin Endocrinol Metab 88:2706–2713

    CAS  PubMed  Google Scholar 

  20. Tsukiyama K, Yamada Y, Yamada C et al (2006) Gastric inhibitory polypeptide as an endogenous factor promoting new bone formation after food ingestion. Mol Endocrinol 20:1644–1651

    CAS  PubMed  Google Scholar 

  21. Bollag RJ, Zhong Q, Phillips P et al (2000) Osteoblast-derived cells express functional glucose-dependent insulinotropic peptide receptors. Endocrinology 141:1228–1235

    CAS  PubMed  Google Scholar 

  22. Zhong Q, Itokawa T, Sridhar S et al (2007) Effects of glucose-dependent insulinotropic peptide on osteoclast function. Am J Physiol Endocrinol Metab 292:E543–E548

    CAS  PubMed  Google Scholar 

  23. Bollag RJ, Zhong Q, Ding KH, Phillips P, Zhong L, Qin F, Cranford J, Mulloy AL, Cameron R, Isales CM (2001) Glucose-dependent insulinotropic peptide is an integrative hormone with osteotropic effects. Mol Cell Endocrinol 177:35–41

    CAS  PubMed  Google Scholar 

  24. Xie D, Cheng H, Hamrick M et al (2005) Glucose-dependent insulinotropic polypeptide receptor knockout mice have altered bone turnover. Bone 37:759–769

    CAS  PubMed  Google Scholar 

  25. Wojcik MH, Meenaghan E, Lawson EA, Misra M, Klibanski A, Miller KK (2010) Reduced amylin levels are associated with low bone mineral density in women with anorexia nervosa. Bone 46:796–800

    CAS  PubMed Central  PubMed  Google Scholar 

  26. Rao RS, Kini S (2011) GIP and bariatric surgery. Obes Surg 21:244–252

    PubMed  Google Scholar 

  27. Date Y, Kojima M, Hosoda H, Sawaguchi A, Mondal MS, Suganuma T, Matsukura S, Kangawa K, Nakazato M (2000) Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology 141:4255–4261

    CAS  PubMed  Google Scholar 

  28. Lehto-Axtelius D, Stenstrom M, Johnell O (1998) Osteopenia after gastrectomy, fundectomy or antrectomy: an experimental study in the rat. Regul Pept 78:41–50

    CAS  PubMed  Google Scholar 

  29. Ohlsson C, Bengtsson BA, Isaksson OG, Andreassen TT, Slootweg MC (1998) Growth hormone and bone. Endocr Rev 19:55–79

    CAS  PubMed  Google Scholar 

  30. Fukushima N, Hanada R, Teranishi H et al (2005) Ghrelin directly regulates bone formation. J Bone Miner Res 20:790–798

    CAS  PubMed  Google Scholar 

  31. Deng F, Ling J, Ma J, Liu C, Zhang W (2008) Stimulation of intramembranous bone repair in rats by ghrelin. Exp Physiol 93:872–879

    CAS  PubMed  Google Scholar 

  32. Maccarinelli G, Sibilia V, Torsello A, Raimondo F, Pitto M, Giustina A, Netti C, Cocchi D (2005) Ghrelin regulates proliferation and differentiation of osteoblastic cells. J Endocrinol 184:249–256

    CAS  PubMed  Google Scholar 

  33. van der Velde M, van der Eerden BC, Sun Y, Almering JM, van der Lely AJ, Delhanty PJ, Smith RG, van Leeuwen JP (2012) An age-dependent interaction with leptin unmasks ghrelin's bone-protective effects. Endocrinology 153:3593–3602

    PubMed  Google Scholar 

  34. Cummings DE, Weigle DS, Frayo RS, Breen PA, Ma MK, Dellinger EP, Purnell JQ (2002) Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 346:1623–1630

    PubMed  Google Scholar 

  35. Pournaras DJ, le Roux CW (2010) Ghrelin and metabolic surgery. Int J Pept 2010:217267. doi:10.1155/2010/217267

  36. Pories WJ (2008) Ghrelin? Yes, it is spelled correctly. Ann Surg 247:408–410

    PubMed  Google Scholar 

  37. le Roux CW, Neary NM, Halsey TJ, Small CJ, Martinez-Isla AM, Ghatei MA, Theodorou NA, Bloom SR (2005) Ghrelin does not stimulate food intake in patients with surgical procedures involving vagotomy. J Clin Endocrinol Metab 90:4521–4524

    PubMed  Google Scholar 

  38. McLaughlin T, Abbasi F, Lamendola C, Frayo RS, Cummings DE (2004) Plasma ghrelin concentrations are decreased in insulin-resistant obese adults relative to equally obese insulin-sensitive controls. J Clin Endocrinol Metab 89:1630–1635

    CAS  PubMed  Google Scholar 

  39. Gutniak M, Orskov C, Holst JJ, Ahren B, Efendic S (1992) Antidiabetogenic effect of glucagon-like peptide-1 (7–36)amide in normal subjects and patients with diabetes mellitus. N Engl J Med 326:1316–1322

    CAS  PubMed  Google Scholar 

  40. Farilla L, Bulotta A, Hirshberg B, Li Calzi S, Khoury N, Noushmehr H, Bertolotto C, Di Mario U, Harlan DM, Perfetti R (2003) Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets. Endocrinology 144:5149–5158

    CAS  PubMed  Google Scholar 

  41. Yamada C, Yamada Y, Tsukiyama K, Yamada K, Udagawa N, Takahashi N, Tanaka K, Drucker DJ, Seino Y, Inagaki N (2008) The murine glucagon-like peptide-1 receptor is essential for control of bone resorption. Endocrinology 149:574–579

    CAS  PubMed  Google Scholar 

  42. Nuche-Berenguer B, Portal-Nunez S, Moreno P, Gonzalez N, Acitores A, Lopez-Herradon A, Esbrit P, Valverde I, Villanueva-Penacarrillo ML (2010) Presence of a functional receptor for GLP-1 in osteoblastic cells, independent of the cAMP-linked GLP-1 receptor. J Cell Physiol 225:585–592

    CAS  PubMed  Google Scholar 

  43. Nuche-Berenguer B, Moreno P, Esbrit P, Dapia S, Caeiro JR, Cancelas J, Haro-Mora JJ, Villanueva-Penacarrillo ML (2009) Effect of GLP-1 treatment on bone turnover in normal, type 2 diabetic, and insulin-resistant states. Calcif Tissue Int 84:453–461

    CAS  PubMed  Google Scholar 

  44. Bunck MC, Eliasson B, Corner A, Heine RJ, Shaginian RM, Taskinen MR, Yki-Jarvinen H, Smith U, Diamant M (2011) Exenatide treatment did not affect bone mineral density despite body weight reduction in patients with type 2 diabetes. Diabetes Obes Metab 13:374–377

    CAS  PubMed  Google Scholar 

  45. Pieber TR, Roitelman J, Lee Y, Luskey KL, Stein DT (1994) Direct plasma radioimmunoassay for rat amylin-(1–37): concentrations with acquired and genetic obesity. Am J Physiol 267:E156–E164

    CAS  PubMed  Google Scholar 

  46. Villa I, Rubinacci A, Ravasi F, Ferrara AF, Guidobono F (1997) Effects of amylin on human osteoblast-like cells. Peptides 18:537–540

    CAS  PubMed  Google Scholar 

  47. Cornish J, Callon KE, Cooper GJ, Reid IR (1995) Amylin stimulates osteoblast proliferation and increases mineralized bone volume in adult mice. Biochem Biophys Res Commun 207:133–139

    CAS  PubMed  Google Scholar 

  48. Alam AS, Moonga BS, Bevis PJ, Huang CL, Zaidi M (1993) Amylin inhibits bone resorption by a direct effect on the motility of rat osteoclasts. Exp Physiol 78:183–196

    CAS  PubMed  Google Scholar 

  49. Cornish J, Callon KE, Bava U, Kamona SA, Cooper GJ, Reid IR (2001) Effects of calcitonin, amylin, and calcitonin gene-related peptide on osteoclast development. Bone 29:162–168

    CAS  PubMed  Google Scholar 

  50. Pietschmann P, Farsoudi KH, Hoffmann O, Klaushofer K, Horandner H, Peterlik M (1993) Inhibitory effect of amylin on basal and parathyroid hormone-stimulated bone resorption in cultured neonatal mouse calvaria. Bone 14:167–172

    CAS  PubMed  Google Scholar 

  51. Cornish J, Callon KE, King AR, Cooper GJ, Reid IR (1998) Systemic administration of amylin increases bone mass, linear growth, and adiposity in adult male mice. Am J Physiol 275:E694–E699

    CAS  PubMed  Google Scholar 

  52. Dacquin R, Davey RA, Laplace C, Levasseur R, Morris HA, Goldring SR, Gebre-Medhin S, Galson DL, Zajac JD, Karsenty G (2004) Amylin inhibits bone resorption while the calcitonin receptor controls bone formation in vivo. J Cell Biol 164:509–514

    CAS  PubMed  Google Scholar 

  53. Zaidi M, Shankar VS, Huang CL, Pazianas M, Bloom SR (1993) Amylin in bone conservation current evidence and hypothetical considerations. Trends Endocrinol Metab 4:255–259

    CAS  PubMed  Google Scholar 

  54. Kowalczyk R, Harris PW, Brimble MA, Callon KE, Watson M, Cornish J (2012) Synthesis and evaluation of disulfide bond mimetics of amylin-(1–8) as agents to treat osteoporosis. Bioorg Med Chem 20:2661–2668

    CAS  PubMed  Google Scholar 

  55. Shin AC, Zheng H, Townsend RL, Sigalet DL, Berthoud HR (2010) Meal-induced hormone responses in a rat model of Roux-en-Y gastric bypass surgery. Endocrinology 151:1588–1597

    CAS  PubMed  Google Scholar 

  56. Kashyap SR, Daud S, Kelly KR, Gastaldelli A, Win H, Brethauer S, Kirwan JP, Schauer PR (2010) Acute effects of gastric bypass versus gastric restrictive surgery on beta-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes. Int J Obes (Lond) 34:462–471

    CAS  Google Scholar 

  57. Jacobsen SH, Olesen SC, Dirksen C et al (2012) Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in non-diabetic subjects. Obes Surg 22:1084–1096

    CAS  PubMed  Google Scholar 

  58. Bose M, Teixeira J, Olivan B, Bawa B, Arias S, Machineni S, Pi-Sunyer FX, Scherer PE, Laferrere B (2010) Weight loss and incretin responsiveness improve glucose control independently after gastric bypass surgery. J Diabetes 2:47–55

    CAS  PubMed  Google Scholar 

  59. Yang J, Zhang X, Wang W, Liu J (2010) Insulin stimulates osteoblast proliferation and differentiation through ERK and PI3K in MG-63 cells. Cell Biochem Funct 28:334–341

    CAS  PubMed  Google Scholar 

  60. Niu T, Rosen CJ (2005) The insulin-like growth factor-I gene and osteoporosis: a critical appraisal. Gene 361:38–56

    CAS  PubMed  Google Scholar 

  61. Dagogo-Jack S, al-Ali N, Qurttom M (1997) Augmentation of bone mineral density in hirsute women. J Clin Endocrinol Metab 82:2821–2825

    CAS  PubMed  Google Scholar 

  62. Thomas DM, Udagawa N, Hards DK, Quinn JM, Moseley JM, Findlay DM, Best JD (1998) Insulin receptor expression in primary and cultured osteoclast-like cells. Bone 23:181–186

    CAS  PubMed  Google Scholar 

  63. Ferron M, Wei J, Yoshizawa T, Del Fattore A, DePinho RA, Teti A, Ducy P, Karsenty G (2010) Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism. Cell 142:296–308

    CAS  PubMed Central  PubMed  Google Scholar 

  64. Cornish J, MacGibbon A, Lin JM et al (2008) Modulation of osteoclastogenesis by fatty acids. Endocrinology 149:5688–5695

    CAS  PubMed  Google Scholar 

  65. Reid IR (2008) Relationships between fat and bone. Osteoporos Int 19:595–606

    CAS  PubMed  Google Scholar 

  66. Yadav VK, Oury F, Suda N et al (2009) A serotonin-dependent mechanism explains the leptin regulation of bone mass, appetite, and energy expenditure. Cell 138:976–989

    CAS  PubMed Central  PubMed  Google Scholar 

  67. Yadav VK, Ryu JH, Suda N et al (2008) Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum. Cell 135:825–837

    CAS  PubMed Central  PubMed  Google Scholar 

  68. Gong Y, Slee RB, Fukai N et al (2001) LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 107:513–523

    CAS  PubMed  Google Scholar 

  69. Boyden LM, Mao J, Belsky J, Mitzner L, Farhi A, Mitnick MA, Wu D, Insogna K, Lifton RP (2002) High bone density due to a mutation in LDL-receptor-related protein 5. N Engl J Med 346:1513–1521

    CAS  PubMed  Google Scholar 

  70. Modder UI, Achenbach SJ, Amin S, Riggs BL, Melton LJ 3rd, Khosla S (2010) Relation of serum serotonin levels to bone density and structural parameters in women. J Bone Miner Res 25:415–422

    CAS  PubMed  Google Scholar 

  71. Schwan S, Hallberg P (2009) SSRIs, bone mineral density, and risk of fractures—a review. Eur Neuropsychopharmacol 19:683–692

    CAS  PubMed  Google Scholar 

  72. Strauss BJ, Marks SJ, Growcott JP, Stroud DB, Lo CS, Dixon JB, O'Brien PE (2003) Body composition changes following laparoscopic gastric banding for morbid obesity. Acta Diabetol 40(Suppl 1):S266–S269

    PubMed  Google Scholar 

  73. DiGiorgi M, Daud A, Inabnet WB, Schrope B, Urban-Skuro M, Restuccia N, Bessler M (2008) Markers of bone and calcium metabolism following gastric bypass and laparoscopic adjustable gastric banding. Obes Surg 18:1144–1148

    PubMed  Google Scholar 

  74. Dixon JB, Strauss BJ, Laurie C, O'Brien PE (2007) Changes in body composition with weight loss: obese subjects randomized to surgical and medical programs. Obesity (Silver Spring) 15:1187–1198

    Google Scholar 

  75. von Mach MA, Stoeckli R, Bilz S, Kraenzlin M, Langer I, Keller U (2004) Changes in bone mineral content after surgical treatment of morbid obesity. Metabolism 53:918–921

    Google Scholar 

  76. Coates PS, Fernstrom JD, Fernstrom MH, Schauer PR, Greenspan SL (2004) Gastric bypass surgery for morbid obesity leads to an increase in bone turnover and a decrease in bone mass. J Clin Endocrinol Metab 89:1061–1065

    CAS  PubMed  Google Scholar 

  77. Riedt CS, Brolin RE, Sherrell RM, Field MP, Shapses SA (2006) True fractional calcium absorption is decreased after Roux-en-Y gastric bypass surgery. Obesity (Silver Spring) 14:1940–1948

    CAS  Google Scholar 

  78. Bruno C, Fulford AD, Potts JR, McClintock R, Jones R, Cacucci BM, Gupta CE, Peacock M, Considine RV (2010) Serum markers of bone turnover are increased at six and 18 months after Roux-en-Y bariatric surgery: correlation with the reduction in leptin. J Clin Endocrinol Metab 95:159–166

    CAS  PubMed  Google Scholar 

  79. Fleischer J, Stein EM, Bessler M, Della Badia M, Restuccia N, Olivero-Rivera L, McMahon DJ, Silverberg SJ (2008) The decline in hip bone density after gastric bypass surgery is associated with extent of weight loss. J Clin Endocrinol Metab 93:3735–3740

    CAS  PubMed  Google Scholar 

  80. El-Kadre LJ, Rocha PR, de Almeida Tinoco AC, Tinoco RC (2004) Calcium metabolism in pre- and postmenopausal morbidly obese women at baseline and after laparoscopic Roux-en-Y gastric bypass. Obes Surg 14:1062–1066

    PubMed  Google Scholar 

  81. Ott MT, Fanti P, Malluche HH, Ryo UY, Whaley FS, Strodel WE, Colacchi TA (1992) Biochemical evidence of metabolic bone disease in women following Roux-Y gastric bypass for morbid obesity. Obes Surg 2:341–348

    PubMed  Google Scholar 

  82. Goode LR, Brolin RE, Chowdhury HA, Shapses SA (2004) Bone and gastric bypass surgery: effects of dietary calcium and vitamin D. Obes Res 12:40–47

    CAS  PubMed  Google Scholar 

  83. Valderas JP, Velasco S, Solari S, Liberona Y, Viviani P, Maiz A, Escalona A, Gonzalez G (2009) Increase of bone resorption and the parathyroid hormone in postmenopausal women in the long-term after Roux-en-Y gastric bypass. Obes Surg 19:1132–1138

    PubMed  Google Scholar 

  84. Beck TJ, Petit MA, Wu G, LeBoff MS, Cauley JA, Chen Z (2009) Does obesity really make the femur stronger? BMD, geometry, and fracture incidence in the women's health initiative-observational study. J Bone Miner Res 24:1369–1379

    PubMed  Google Scholar 

  85. Gomez JM, Vilarrasa N, Masdevall C, Pujol J, Solano E, Soler J, Elio I, Gallart L, Vendrell J (2009) Regulation of bone mineral density in morbidly obese women: a cross-sectional study in two cohorts before and after bypass surgery. Obes Surg 19:345–350

    PubMed  Google Scholar 

  86. Vilarrasa N, San Jose P, Garcia I, Gomez-Vaquero C, Miras PM, de Gordejuela AG, Masdevall C, Pujol J, Soler J, Gomez JM (2011) Evaluation of bone mineral density loss in morbidly obese women after gastric bypass: 3-year follow-up. Obes Surg 21:465–472

    PubMed  Google Scholar 

  87. Vilarrasa N, Gomez JM, Elio I et al (2009) Evaluation of bone disease in morbidly obese women after gastric bypass and risk factors implicated in bone loss. Obes Surg 19:860–866

    PubMed  Google Scholar 

  88. Casagrande DS, Repetto G, Mottin CC, Shah J, Pietrobon R, Worni M, Schaan BD (2012) Changes in bone mineral density in women following 1-year gastric bypass surgery. Obes Surg 22:1287–1292

    PubMed  Google Scholar 

  89. Carrasco F, Ruz M, Rojas P et al (2009) Changes in bone mineral density, body composition and adiponectin levels in morbidly obese patients after bariatric surgery. Obes Surg 19:41–46

    PubMed  Google Scholar 

  90. Mahdy T, Atia S, Farid M, Adulatif A (2008) Effect of Roux-en Y gastric bypass on bone metabolism in patients with morbid obesity: Mansoura experiences. Obes Surg 18:1526–1531

    PubMed  Google Scholar 

  91. Yu EW, Thomas BJ, Brown JK, Finkelstein JS (2012) Simulated increases in body fat and errors in bone mineral density measurements by DXA and QCT. J Bone Miner Res 27:119–124

    PubMed  Google Scholar 

  92. Hangartner TN, Johnston CC (1990) Influence of fat on bone measurements with dual-energy absorptiometry. Bone Miner 9:71–81

    CAS  PubMed  Google Scholar 

  93. Tothill P, Laskey MA, Orphanidou CI, van Wijk M (1999) Anomalies in dual energy X-ray absorptiometry measurements of total-body bone mineral during weight change using Lunar, Hologic and Norland instruments. Br J Radiol 72:661–669

    CAS  PubMed  Google Scholar 

  94. Madsen OR, Jensen JE, Sorensen OH (1997) Validation of a dual energy X-ray absorptiometer: measurement of bone mass and soft tissue composition. Eur J Appl Physiol Occup Physiol 75:554–558

    CAS  PubMed  Google Scholar 

  95. Bolotin HH (2007) DXA in vivo BMD methodology: an erroneous and misleading research and clinical gauge of bone mineral status, bone fragility, and bone remodelling. Bone 41:138–154

    CAS  PubMed  Google Scholar 

  96. Berarducci A, Haines K, Murr MM (2009) Incidence of bone loss, falls, and fractures after Roux-en-Y gastric bypass for morbid obesity. Appl Nurs Res 22:35–41

    PubMed  Google Scholar 

  97. Lalmohamed A, de Vries F, Bazelier MT, Cooper A, van Staa TP, Cooper C, Harvey NC (2012) Risk of fracture after bariatric surgery in the United Kingdom: population based, retrospective cohort study. BMJ 345:e5085

    PubMed Central  PubMed  Google Scholar 

  98. Robling AG, Bellido T, Turner CH (2006) Mechanical stimulation in vivo reduces osteocyte expression of sclerostin. J Musculoskelet Neuronal Interact 6:354

    CAS  PubMed  Google Scholar 

  99. Bonewald LF, Johnson ML (2008) Osteocytes, mechanosensing and Wnt signaling. Bone 42:606–615

    CAS  PubMed Central  PubMed  Google Scholar 

  100. Armamento-Villareal R, Sadler C, Napoli N, Shah K, Chode S, Sinacore DR, Qualls C, Villareal DT (2012) Weight loss in obese older adults increases serum sclerostin and impairs hip geometry but both are prevented by exercise training. J Bone Miner Res 27:1215–1221

    CAS  PubMed Central  PubMed  Google Scholar 

  101. Bell NH, Epstein S, Greene A, Shary J, Oexmann MJ, Shaw S (1985) Evidence for alteration of the vitamin D-endocrine system in obese subjects. J Clin Invest 76:370–373

    CAS  PubMed Central  PubMed  Google Scholar 

  102. Compston JE, Vedi S, Ledger JE, Webb A, Gazet JC, Pilkington TR (1981) Vitamin D status and bone histomorphometry in gross obesity. Am J Clin Nutr 34:2359–2363

    CAS  PubMed  Google Scholar 

  103. Ybarra J, Sanchez-Hernandez J, Gich I, De Leiva A, Rius X, Rodriguez-Espinosa J, Perez A (2005) Unchanged hypovitaminosis D and secondary hyperparathyroidism in morbid obesity after bariatric surgery. Obes Surg 15:330–335

    PubMed  Google Scholar 

  104. Sanchez-Hernandez J, Ybarra J, Gich I, De Leiva A, Rius X, Rodriguez-Espinosa J, Perez A (2005) Effects of bariatric surgery on vitamin D status and secondary hyperparathyroidism: a prospective study. Obes Surg 15:1389–1395

    PubMed  Google Scholar 

  105. Johnson JM, Maher JW, DeMaria EJ, Downs RW, Wolfe LG, Kellum JM (2006) The long-term effects of gastric bypass on vitamin D metabolism. Ann Surg 243:701–704, discussion 704–705

    PubMed  Google Scholar 

  106. Holick MF (2003) Vitamin D: A millenium perspective. J Cell Biochem 88:296–307

    CAS  PubMed  Google Scholar 

  107. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96:1911–1930

    CAS  PubMed  Google Scholar 

  108. Dawson-Hughes B, Mithal A, Bonjour JP, Boonen S, Burckhardt P, Fuleihan GE, Josse RG, Lips P, Morales-Torres J, Yoshimura N (2010) IOF position statement: vitamin D recommendations for older adults. Osteoporos Int 21:1151–1154

    CAS  PubMed  Google Scholar 

  109. Bloomberg RD, Fleishman A, Nalle JE, Herron DM, Kini S (2005) Nutritional deficiencies following bariatric surgery: what have we learned? Obes Surg 15:145–154

    PubMed  Google Scholar 

  110. Bolland MJ, Grey AB, Ames RW, Horne AM, Gamble GD, Reid IR (2006) Fat mass is an important predictor of parathyroid hormone levels in postmenopausal women. Bone 38:317–321

    CAS  PubMed  Google Scholar 

  111. Snijder MB, van Dam RM, Visser M, Deeg DJ, Dekker JM, Bouter LM, Seidell JC, Lips P (2005) Adiposity in relation to vitamin D status and parathyroid hormone levels: a population-based study in older men and women. J Clin Endocrinol Metab 90:4119–4123

    CAS  PubMed  Google Scholar 

  112. Ostrowska Z, Zwirska-Korczala K, Buntner B, Pardela M, Drozdz M (1998) Assessment of bone metabolism in obese women. Endocr Regul 32:177–181

    CAS  PubMed  Google Scholar 

  113. Kamycheva E, Sundsfjord J, Jorde R (2004) Serum parathyroid hormone level is associated with body mass index. The 5th Tromso study. Eur J Endocrinol 151:167–172

    CAS  PubMed  Google Scholar 

  114. Diniz Mde F, Diniz MT, Sanches SR, Salgado PP, Valadao MM, Araujo FC, Martins DS, Rocha AL (2004) Elevated serum parathormone after Roux-en-Y gastric bypass. Obes Surg 14:1222–1226

    PubMed  Google Scholar 

  115. Youssef Y, Richards WO, Sekhar N, Kaiser J, Spagnoli A, Abumrad N, Torquati A (2007) Risk of secondary hyperparathyroidism after laparoscopic gastric bypass surgery in obese women. Surg Endosc 21:1393–1396

    CAS  PubMed  Google Scholar 

  116. Sahota O, Mundey MK, San P, Godber IM, Hosking DJ (2006) Vitamin D insufficiency and the blunted PTH response in established osteoporosis: the role of magnesium deficiency. Osteoporos Int 17:1013–1021

    CAS  PubMed  Google Scholar 

  117. Johansson HE, Zethelius B, Ohrvall M, Sundbom M, Haenni A (2009) Serum magnesium status after gastric bypass surgery in obesity. Obes Surg 19:1250–1255

    PubMed  Google Scholar 

  118. Rizzoli R, Bonjour JP (2004) Dietary protein and bone health. J Bone Miner Res 19:527–531

    PubMed  Google Scholar 

  119. Aaseth J, Boivin G, Andersen O (2012) Osteoporosis and trace elements—an overview. J Trace Elem Med Biol 26:149–152

    CAS  PubMed  Google Scholar 

  120. Zhao LJ, Jiang H, Papasian CJ, Maulik D, Drees B, Hamilton J, Deng HW (2008) Correlation of obesity and osteoporosis: effect of fat mass on the determination of osteoporosis. J Bone Miner Res 23:17–29

    CAS  PubMed  Google Scholar 

  121. Confavreux CB, Levine RL, Karsenty G (2009) A paradigm of integrative physiology, the crosstalk between bone and energy metabolisms. Mol Cell Endocrinol 310:21–29

    CAS  PubMed Central  PubMed  Google Scholar 

  122. Lee NK, Karsenty G (2008) Reciprocal regulation of bone and energy metabolism. Trends Endocrinol Metab 19:161–166

    CAS  PubMed  Google Scholar 

  123. Himms-Hagen J (1999) Physiological roles of the leptin endocrine system: differences between mice and humans. Crit Rev Clin Lab Sci 36:575–655

    CAS  PubMed  Google Scholar 

  124. Considine RV, Sinha MK, Heiman ML et al (1996) Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334:292–295

    CAS  PubMed  Google Scholar 

  125. Cornish J, Callon KE, Bava U et al (2002) Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo. J Endocrinol 175:405–415

    CAS  PubMed  Google Scholar 

  126. Gordeladze JO, Drevon CA, Syversen U, Reseland JE (2002) Leptin stimulates human osteoblastic cell proliferation, de novo collagen synthesis, and mineralization: impact on differentiation markers, apoptosis, and osteoclastic signaling. J Cell Biochem 85:825–836

    CAS  PubMed  Google Scholar 

  127. Thomas T (2004) The complex effects of leptin on bone metabolism through multiple pathways. Curr Opin Pharmacol 4:295–300

    CAS  PubMed  Google Scholar 

  128. Reseland JE, Syversen U, Bakke I, Qvigstad G, Eide LG, Hjertner O, Gordeladze JO, Drevon CA (2001) Leptin is expressed in and secreted from primary cultures of human osteoblasts and promotes bone mineralization. J Bone Miner Res 16:1426–1433

    CAS  PubMed  Google Scholar 

  129. Holloway WR, Collier FM, Aitken CJ, Myers DE, Hodge JM, Malakellis M, Gough TJ, Collier GR, Nicholson GC (2002) Leptin inhibits osteoclast generation. J Bone Miner Res 17:200–209

    CAS  PubMed  Google Scholar 

  130. Burguera B, Hofbauer LC, Thomas T, Gori F, Evans GL, Khosla S, Riggs BL, Turner RT (2001) Leptin reduces ovariectomy-induced bone loss in rats. Endocrinology 142:3546–3553

    CAS  PubMed  Google Scholar 

  131. Steppan CM, Crawford DT, Chidsey-Frink KL, Ke H, Swick AG (2000) Leptin is a potent stimulator of bone growth in ob/ob mice. Regul Pept 92:73–78

    CAS  PubMed  Google Scholar 

  132. Ducy P, Amling M, Takeda S, Priemel M, Schilling AF, Beil FT, Shen J, Vinson C, Rueger JM, Karsenty G (2000) Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 100:197–207

    CAS  PubMed  Google Scholar 

  133. Takeda S, Elefteriou F, Levasseur R, Liu X, Zhao L, Parker KL, Armstrong D, Ducy P, Karsenty G (2002) Leptin regulates bone formation via the sympathetic nervous system. Cell 111:305–317

    CAS  PubMed  Google Scholar 

  134. Yadav VK, Karsenty G (2009) Leptin-dependent co-regulation of bone and energy metabolism. Aging (Albany NY) 1:954–956

    CAS  Google Scholar 

  135. Karsenty G (2006) Convergence between bone and energy homeostases: leptin regulation of bone mass. Cell Metab 4:341–348

    CAS  PubMed  Google Scholar 

  136. Weiss LA, Barrett-Connor E, von Muhlen D, Clark P (2006) Leptin predicts BMD and bone resorption in older women but not older men: the Rancho Bernardo study. J Bone Miner Res 21:758–764

    CAS  PubMed  Google Scholar 

  137. Pasco JA, Henry MJ, Kotowicz MA, Collier GR, Ball MJ, Ugoni AM, Nicholson GC (2001) Serum leptin levels are associated with bone mass in nonobese women. J Clin Endocrinol Metab 86:1884–1887

    CAS  PubMed  Google Scholar 

  138. Blain H, Vuillemin A, Guillemin F, Durant R, Hanesse B, de Talance N, Doucet B, Jeandel C (2002) Serum leptin level is a predictor of bone mineral density in postmenopausal women. J Clin Endocrinol Metab 87:1030–1035

    CAS  PubMed  Google Scholar 

  139. Zoico E, Zamboni M, Adami S, Vettor R, Mazzali G, Tosoni P, Bissoli L, Bosello O (2003) Relationship between leptin levels and bone mineral density in the elderly. Clin Endocrinol (Oxf) 59:97–103

    CAS  Google Scholar 

  140. Martini G, Valenti R, Giovani S, Franci B, Campagna S, Nuti R (2001) Influence of insulin-like growth factor-1 and leptin on bone mass in healthy postmenopausal women. Bone 28:113–117

    CAS  PubMed  Google Scholar 

  141. Goulding A, Taylor RW (1998) Plasma leptin values in relation to bone mass and density and to dynamic biochemical markers of bone resorption and formation in postmenopausal women. Calcif Tissue Int 63:456–458

    CAS  PubMed  Google Scholar 

  142. Maffei M, Halaas J, Ravussin E et al (1995) Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1:1155–1161

    CAS  PubMed  Google Scholar 

  143. Peake PW, Kriketos AD, Campbell LV, Shen Y, Charlesworth JA (2005) The metabolism of isoforms of human adiponectin: studies in human subjects and in experimental animals. Eur J Endocrinol 153:409–417

    CAS  PubMed  Google Scholar 

  144. Berner HS, Lyngstadaas SP, Spahr A, Monjo M, Thommesen L, Drevon CA, Syversen U, Reseland JE (2004) Adiponectin and its receptors are expressed in bone-forming cells. Bone 35:842–849

    CAS  PubMed  Google Scholar 

  145. Williams GA, Wang Y, Callon KE et al (2009) In vitro and in vivo effects of adiponectin on bone. Endocrinology 150:3603–3610

    CAS  PubMed  Google Scholar 

  146. Biver E, Salliot C, Combescure C, Gossec L, Hardouin P, Legroux-Gerot I, Cortet B (2011) Influence of adipokines and ghrelin on bone mineral density and fracture risk: a systematic review and meta-analysis. J Clin Endocrinol Metab 96:2703–2713

    CAS  PubMed  Google Scholar 

  147. Oshima K, Nampei A, Matsuda M, Iwaki M, Fukuhara A, Hashimoto J, Yoshikawa H, Shimomura I (2005) Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast. Biochem Biophys Res Commun 331:520–526

    CAS  PubMed  Google Scholar 

  148. Luo XH, Guo LJ, Yuan LQ, Xie H, Zhou HD, Wu XP, Liao EY (2005) Adiponectin stimulates human osteoblasts proliferation and differentiation via the MAPK signaling pathway. Exp Cell Res 309:99–109

    CAS  PubMed  Google Scholar 

  149. Yamaguchi N, Kukita T, Li YJ, Martinez Argueta JG, Saito T, Hanazawa S, Yamashita Y (2007) Adiponectin inhibits osteoclast formation stimulated by lipopolysaccharide from Actinobacillus actinomycetemcomitans. FEMS Immunol Med Microbiol 49:28–34

    CAS  PubMed  Google Scholar 

  150. Shinoda Y, Yamaguchi M, Ogata N et al (2006) Regulation of bone formation by adiponectin through autocrine/paracrine and endocrine pathways. J Cell Biochem 99:196–208

    CAS  PubMed  Google Scholar 

  151. Riggs BL, Khosla S, Melton LJ 3rd (2002) Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev 23:279–302

    CAS  PubMed  Google Scholar 

  152. Rao SR, Kini S, Tamler R (2011) Sex hormones and bariatric surgery in men. Gend Med 8:300–311

    PubMed  Google Scholar 

  153. Karsenty G (2012) The mutual dependence between bone and gonads. J Endocrinol 213:107–114

    CAS  PubMed  Google Scholar 

  154. Guney E, Kisakol G, Ozgen G, Yilmaz C, Yilmaz R, Kabalak T (2003) Effect of weight loss on bone metabolism: comparison of vertical banded gastroplasty and medical intervention. Obes Surg 13:383–388

    PubMed  Google Scholar 

  155. Hammoud A, Gibson M, Hunt SC, Adams TD, Carrell DT, Kolotkin RL, Meikle AW (2009) Effect of Roux-en-Y gastric bypass surgery on the sex steroids and quality of life in obese men. J Clin Endocrinol Metab 94:1329–1332

    CAS  PubMed  Google Scholar 

  156. Mauras N, Haymond MW, Darmaun D, Vieira NE, Abrams SA, Yergey AL (1994) Calcium and protein kinetics in prepubertal boys. Positive effects of testosterone. J Clin Invest 93:1014–1019

    CAS  PubMed Central  PubMed  Google Scholar 

  157. Hope WG, Ibarra MJ, Thomas ML (1992) Testosterone alters duodenal calcium transport and longitudinal bone growth rate in parallel in the male rat. Proc Soc Exp Biol Med 200:536–541

    CAS  PubMed  Google Scholar 

  158. Couchourel D, Leclerc M, Filep J, Brunette MG (2004) Testosterone enhances calcium reabsorption by the kidney. Mol Cell Endocrinol 222:71–81

    CAS  PubMed  Google Scholar 

  159. Carnevale V, Romagnoli E, Cipriani C, Del Fiacco R, Piemonte S, Pepe J, Scillitani A, Minisola S (2010) Sex hormones and bone health in males. Arch Biochem Biophys 503:110–117

    CAS  PubMed  Google Scholar 

  160. Hammoud AO, Gibson M, Peterson CM, Meikle AW, Carrell DT (2008) Impact of male obesity on infertility: a critical review of the current literature. Fertil Steril 90:897–904

    PubMed  Google Scholar 

  161. Hammoud AO, Wilde N, Gibson M, Parks A, Carrell DT, Meikle AW (2008) Male obesity and alteration in sperm parameters. Fertil Steril 90:2222–2225

    PubMed  Google Scholar 

  162. Mellstrom D, Johnell O, Ljunggren O, Eriksson AL, Lorentzon M, Mallmin H, Holmberg A, Redlund-Johnell I, Orwoll E, Ohlsson C (2006) Free testosterone is an independent predictor of BMD and prevalent fractures in elderly men: MrOS Sweden. J Bone Miner Res 21:529–535

    PubMed  Google Scholar 

Download references

Conflicts of interest

None.

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Division of Endocrinology, Calcium Metabolism and Osteoporosis Program, WHO Collaborating Center for Metabolic Bone Disorders, American University of Beirut-Medical Center, PO BOX: 11-0236, Riad El Solh, 1107 2020, Beirut, Lebanon

    M. P. Hage & G. El-Hajj Fuleihan

Authors
  1. M. P. Hage
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. El-Hajj Fuleihan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to G. El-Hajj Fuleihan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hage, M.P., El-Hajj Fuleihan, G. Bone and mineral metabolism in patients undergoing Roux-en-Y gastric bypass. Osteoporos Int 25, 423–439 (2014). https://doi.org/10.1007/s00198-013-2480-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00198-013-2480-9

Keywords

Search

Navigation